Healthcare provider profile · identity verified

Geetu Pahlajani, M.D

Family Practice · PARMA, OH · NPI 1982923587

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	833	233
Lisinopril	Lisinopril	680	179
Amlodipine Besylate	Amlodipine Besylate	524	144
Levothyroxine Sodium	Levothyroxine Sodium	478	112
Simvastatin	Simvastatin	352	102
Hydrochlorothiazide	Hydrochlorothiazide	343	88
Metoprolol Succinate	Metoprolol Succinate	331	89
Omeprazole	Omeprazole	302	73
Sertraline Hcl	Sertraline Hcl	225	47
Metformin Hcl	Metformin Hcl	223	71
Pantoprazole Sodium	Pantoprazole Sodium	219	57
Rosuvastatin Calcium	Rosuvastatin Calcium	215	70
Losartan Potassium	Losartan Potassium	214	66
Albuterol Sulfate Hfa	Albuterol Sulfate	189	77
Metoprolol Tartrate	Metoprolol Tartrate	187	55
Gabapentin	Gabapentin	176	47
Tizanidine Hcl	Tizanidine Hcl	159	66
Fluticasone Propionate	Fluticasone Propionate	153	69
Escitalopram Oxalate	Escitalopram Oxalate	151	35
Metformin Hcl Er	Metformin Hcl	131	37
Famotidine	Famotidine	130	38
Montelukast Sodium	Montelukast Sodium	120	31
Tamsulosin Hcl	Tamsulosin Hcl	105	27
Trazodone Hcl	Trazodone Hcl	102	26
Ezetimibe	Ezetimibe	91	27
Glipizide Er	Glipizide	86	28
Trulicity	Dulaglutide	82	13
Meloxicam	Meloxicam	81	32
Atenolol	Atenolol	80	28
Citalopram Hbr	Citalopram Hydrobromide	79	20
Pravastatin Sodium	Pravastatin Sodium	79	27
Allopurinol	Allopurinol	78	22
Esomeprazole Magnesium	Esomeprazole Magnesium	77	21
Venlafaxine Hcl Er	Venlafaxine Hcl	76	17
Furosemide	Furosemide	73	27
Glipizide	Glipizide	73	21
Oxybutynin Chloride Er	Oxybutynin Chloride	71	13
Eliquis	Apixaban	64	16
Prednisone	Prednisone	61	44
Ropinirole Hcl	Ropinirole Hcl	61	12
Hydralazine Hcl	Hydralazine Hcl	59	14
Xarelto	Rivaroxaban	58	18
Fenofibrate	Fenofibrate Nanocrystallized	57	12
Alendronate Sodium	Alendronate Sodium	56	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	16
Paroxetine Hcl	Paroxetine Hcl	52	15
Amitriptyline Hcl	Amitriptyline Hcl	51	12
Ibuprofen	Ibuprofen	49	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	12
Alprazolam	Alprazolam	47	suppressed
Finasteride	Finasteride	47	11
Azithromycin	Azithromycin	45	35
Buspirone Hcl	Buspirone Hcl	45	11
Diclofenac Sodium	Diclofenac Sodium	45	16
Duloxetine Hcl	Duloxetine Hcl	45	14
Ozempic	Semaglutide	45	13
Lovastatin	Lovastatin	44	13
Celecoxib	Celecoxib	43	suppressed
Clopidogrel	Clopidogrel Bisulfate	40	14
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	39	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	38	13
Triamcinolone Acetonide	Triamcinolone Acetonide	37	24
Baclofen	Baclofen	34	suppressed
Bupropion Hcl Sr	Bupropion Hcl	34	11
Bupropion Xl	Bupropion Hcl	33	suppressed
Ketoconazole	Ketoconazole	33	suppressed
Clonazepam	Clonazepam	32	suppressed
Lidocaine	Lidocaine	32	suppressed
Symbicort	Budesonide/Formoterol Fumarate	31	12
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Naproxen	Naproxen	29	suppressed
Fluocinonide	Fluocinonide	28	13
Hydrocortisone	Hydrocortisone	28	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	11
Potassium Chloride	Potassium Chloride	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	suppressed
Januvia	Sitagliptin Phosphate	27	11
Mupirocin	Mupirocin	27	20
Valacyclovir	Valacyclovir Hcl	27	suppressed
Carvedilol	Carvedilol	26	suppressed
Lorazepam	Lorazepam	26	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Valsartan	Valsartan	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	13
Acyclovir	Acyclovir	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Carbamazepine	Carbamazepine	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Temazepam	Temazepam	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	17
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	19	19
Jardiance	Empagliflozin	19	suppressed
Methylprednisolone	Methylprednisolone	19	19
Nystatin	Nystatin	19	15
Warfarin Sodium	Warfarin Sodium	19	suppressed
Fluconazole	Fluconazole	18	14
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Atrovent Hfa	Ipratropium Bromide	15	suppressed
Cephalexin	Cephalexin	15	11
Methocarbamol	Methocarbamol	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Scopolamine	Scopolamine	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Colchicine	Colchicine	14	suppressed
Diazepam	Diazepam	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Peg-3350 And Electrolytes	Peg3350/Sod Sulf,bicarb,cl/Kcl	14	14
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Elmiron	Pentosan Polysulfate Sodium	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Trospium Chloride	Trospium Chloride	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error